Physician profile
Todd K Haruki
NPI 1801924659
$14,455.57
in general payments reported to CMS, 2019-2025
9 companies · $2,258 in 2025
The $2,258 reported for 2025 was more than what 90% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $344 · 2021: $565 · 2022: $3,217 · 2023: $683 · 2024: $6,786 · 2025: $2,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,201 · Food and Beverage: $4,327 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,201.02 |
| Food and Beverage | $4,326.99 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $10,332.59 | 2022-2025 | |
| Kls-Martin L.P. | $2,375.75 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $977.14 | 2019-2021 | |
| Nobel Biocare USA | $237.14 | 2019-2021 | |
| Straumann USA LLC | $232.52 | 2021-2024 | |
| Salvin Dental Specialties, INC. | $112.08 | 2019 | |
| Patterson Companies, INC. | $101.68 | 2021-2025 | |
| Align Technology, INC. | $75.00 | 2025 | Invisalign |
| Dentsply Sirona INC | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Haruki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.